Skip to main content
. 2016 Dec 19;14(1):148–153. doi: 10.1007/s13311-016-0497-4

Fig. 2.

Fig. 2

Biomarker properties of urate across the timeline of Parkinson’s disease (PD). Several studies support urate or its determinants (dietary or genetic) as a biomarker of PD at different points in the PD stage, which refers to Hoehn and Yahr scale stage